Home
Conditions
Neuroectodermal Tumors, Primitive

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

732 public trials 120 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Recruiting

CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation

NCT07085325

Conditions: Glioma, Medulloblastoma, Neoplasms, +7 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

NCT06625190

Conditions: Alveolar Soft Part Sarcoma, Chordoma, Clear Cell Sarcoma, +51 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Recruiting

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

NCT07492316

Conditions: Glioma, Medulloblastoma, Neoplasms, +8 more
Locations: UF Health Shands Children's Hospital Gainesville, Florida, United States

View Trial Details

Recruiting

Familial Investigations of Childhood Cancer Predisposition

NCT03050268

Conditions: AML, Abnormalities, Multiple, Acute Leukemia, +206 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

NCT06041516

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +24 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children

NCT07318831

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +9 more
Locations: Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

NCT06607692

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +57 more
Locations: HM Monteprincipe Boadilla del Monte, Madrid, Spain

View Trial Details

Recruiting

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

NCT00107289

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

68Ga-DOTATATE Neuroblastoma Imaging Pilot

NCT04559217

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: McGill University Health Center - Children's hospital Montreal, Quebec, Canada

CHU Ste-Justine Montreal, Quebec, Canada

CIUSSS de l'Estrie-CHUS Hospital Sherbrooke, Quebec, Canada

View Trial Details

Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

NCT04901702

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +55 more
Locations: Lucille Packard Children's Hospital Stanford Palo Alto, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Children's Healthcare of Atlanta/Emory University School of Medicine Atlanta, Georgia, United States

View Trial Details

Neuroectodermal Tumors, Primitive

Neuroectodermal Tumors, Primitive trial results

Related conditions